ADMP News and Press, Adamis Pharmaceuticals Corporation From 06/09/21

Gainers: Aethlon Medical AEMD +425%, Checkpoint Therapeutics CKPT +26%, Adamis Pharmaceuticals ADMP +12%, SCWorx (WORX) +18%, ZIOPHARM Oncology ZIOP +15%.Losers: Atossa Therapeutics ATOS -14%, CEL-SCI CVM -11%, Precipio (PR...

Aethlon Medical (AEMD) +280% after publication of its case studies of critically ill COVID-19 patients treated with the Aethlon Hemopurifier®.Checkpoint Therapeutics (CKPT) +50%.Antelope Enterprise Holdings Limited (AEHL) +45%.SPI Energy (SPI) +41% as its group Company is build...

The FDA has accepted for review Adamis Pharmaceuticals' (ADMP) resubmitted New Drug Application ((NDA)) for Zimhi, which is its higher naloxone injection product candidate for the treatment of opioid overdose.ADMP shares surge 18% premarket trading at $1.19.The FDA also provided PDU...

SAN DIEGO, June 09, 2021 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the Company’s resubmitted New Drug Application (NDA) for ZIMHI™, which is its higher nalo...

Ra Medical Systems (RMED) +56%.Liminal BioSciences (LMNL) +42%.NextDecade Corporation (NEXT) +30%.U.S. Concrete (USCR) +28% as Vulcan Materials buys the Company in $1.3B deal.QTS Realty Trust (QTS) +20% on being acquired by Blackstone funds for $78/share.ChromaDex Corporation (CDXC)...

Adamis Pharmaceuticals (ADMP) jumps 9% premarket following an announcement that the National Institutes of Health ((NIH)) has identified its experimental drug, Tempol, as a potentially potent antiviral for COVID-19.According to a study of cell cultures conducted by NIH, Tempol demon...

Gainers: SemiLEDs (LEDS) +66%.Senseonics (SENS) +49%.Windtree Therapeutics (WINT) +38%.MoSys (MOSY) +34%.Ra Medical Systems (RMED) +29%.LightPath Technologies (LPTH) +27%.American Superconductor (AMSC) +26%.Smart Sand (SND) +25%.The9 (NCTY) +24%.Vinco Ventures (BBIG) +22%....

Gainers: Windtree Therapeutics (WINT) +57%, Senseonics (SENS) +38%, Ra Medical Systems (RMED) +22%, Cullinan Oncology (CGEM) +20%, Progenity (PROG) +10%.Losers: Harpoon Therapeutics (HARP) -25%, Purple Biotech (PPBT) -19%, Adamis Pha...

Micro-cap biopharmaceutical company Adamis Pharmaceuticals ([[ADMP]] +55.7%) quickly surged prompting a trading halt in reaction to a statement from the U.S. National Institute of Health indicating the potential of TEMPOL as an oral antiviral therapy against COVID-19.In February, Adamis annou...

Adamis Pharmaceuticals (ADMP) has received a notification letter from the Nasdaq Stock Market notifying the company that it is not in compliance with the exchange's listing requirements after failing to file its quarterly report on Form 10-Q on time.The notice also indicated that the com...